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Alterations in the chromatin structure of endogenous mouse mammary tumor virus genes accompany
glucocorticoid induction of viral RNA synthesis in the C57BL/6 T lymphoma cell line TlMl. These alterations
are defined by the appearance of sites of DNase I hypersensitivity within proviral DNA in isolated nuclei, as well
as by changes in the moderate nuclease sensitivity of entire proviral transcription units. Induced hypersensitive
sites, termed type I, appear with a time course comparable to that required for induction of the rate of viral
RNA synthesis and are maintained only in the continuous presence of hormone. Two such sites map to
analogous positions in the 5' and 3' long terminal repeats of proviral DNA within, or very near, sequences that
have been shown to comprise positions of specific binding of the glucocorticoid receptor in vitro and that are
required for hormone-inducible transcription in vivo. A third type I site maps to another position of in vitro
receptor binding near the 3' long terminal repeat. Some sites of DNase I hypersensitivity, termed type II,
appear not to be markedly hormone dependent; two such sites are present in corresponding positions in each
long terminal repeat. Comparison of the moderate DNase I sensitivity of mouse mammary tumor virus proviral
DNA suggests that the three different endogenous units in TlMl cells can be maintained in distinct chromatin
conformations that are determined by factors related to the site of provirus insertion. It seems possible that
altered chromatin conformations may reflect, or actually encode, important mechanistic features of these
hormone-responsive genes.
The RNA genome of mouse mammary tumor virus
(MMTV), a retrovirus, is encoded by proviral DNA cova-
lently integrated into the nuclear DNA of infected cells.
Glucocorticoid hormones rapidly and selectively activate
transcription of these proviral genes by a mechanism that
requires functional glucocorticoid receptor proteins (13) and
results in an increase in the frequency of transcription
initiation at sites that are identical to those that are used with
lower efficiency in the absence of hormone (29, 36). In vitro,
purified glucocorticoid receptor protein has been shown to
bind specifically to a 340-base-pair (bp) restriction fragment
from the MMTV long terminal repeat (LTR) (10, 12, 25, 26,
28, 31). This fragment, termed the glucocorticoid response
element (GRE), is able to confer hormone inducibility on
heterologous promoters to which it is linked in cis, and many
of its properties are similar to those of enhancer elements
(4). The abundance of hormonally induced transcripts and,
in some cases, the ability of hormones to affect transcription
at all appear to be a function of the chromosomal site of
provirus insertion (9). Thus, there are apparently two levels
at which viral transcription is regulated: the specific interac-
tion of the glucocorticoid receptor with the GRE and a much
less clearly defined position effect that may determine
whether a productive interaction between the receptor and
DNA can occur.
MMTV proviral DNA is endogenous to all inbred strains
of mice and to many feral populations. These endogenous
sequences are stable genetic elements; their number and
genomic location are a characteristic of each inbred strain.
Endogenous MMTV genes of many mouse strains are not
actively transcribed. For example, C57BL/6 mice contain
three apparently intact copies of proviral DNA (27), but
MMTV RNA cannot be detected in any tissue, with the
possible exception of lactating mammary gland, where small
amounts of viral RNA have been detected in some studies
(19, 39).
Surprisingly, hormone-inducible synthesis ofMMTV RNA
has been detected in the C57BL/6 T lymphoma cell line
TlMl (21, 34). These cells contain the endogenous units of
MMTV proviral DNA present at the genetic loci Mtv-8 (unit
II), Mtv-9 (unit III), and Mtv-17 (unit XI) that are character-
istic of other C57BL/6 cells in which viral RNA is not
synthesized (27).
Experiments presented in this paper take advantage of the
unique properties ofTlMl cells to determine whether gluco-
corticoid-stimulated transcription can be correlated with
alterations in the structure ofMMTV chromatin and to begin
to assess the possible role of altered chromatin conforma-
tions in programming the potential for transcriptional acti-
vation of the individual endogenous proviral genes.
MATERIALS AND METHODS
Cell culture. TlMl is a T-cell lymphoma derived from the
C57BL/6 mouse strain (22, 34). Cells were grown in suspen-
sion in Dulbecco modified Eagle medium (GIBCO Labora-
tories) containing 10% horse serum (KC Biologicals) in an
atmosphere of 5% CO2 saturated with water. Cell densities
were maintained below 106/ml.
Preparation of nuclei. All steps in the preparation of nuclei
were performed at 0 to 4°C. Cells were washed twice in
isotonic saline solution and then suspended in a hypotonic
solution composed of 10 mM Tris-hydrochloride (pH 7.6), 10
mM NaCl, and 3 mM MgCl2 at a cell density of 0.5 x 108 to
1 x 108 cells per ml. After 10 min on ice, cells were broken
in a Dounce homogenizer fitted with a type A pestle. Cell
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FIG. 1. Maps of MMTV DNA in TlMl cells. MMTV sequences are shown as double lines; flanking DNA is shown as single lines. LTRs
are indicated by hatched boxes. The arrow indicates the cap site and direction ofMMTV RNA transcription. The restriction maps are taken
from Peterson et al. (27).
eted by centrifugation at 100 x g for 7 min and were washed
twice in DNase I digestion buffer (20) (10 mM Tris-hydro-
chloride [pH 7.6], 0.1 M NaCl, 6 mM MgCl2, 1 mM 2-mer-
captoethanol, and 0.1 mM phenylmethylsulfonyl fluoride).
Immediately preceding the final centrifugation step, the
nuclei were counted in a hemacytometer, and the final
nuclear suspension in DNase I digestion buffer was made at
a density of 107/ml. Nuclei from cells that had been treated
with dexamethasone before nuclear isolation were prepared
with 10-7 M dexamethasone in all solutions.
DNase I digestion of nuclei. Before treatment with DNase
I, CaCl2 was added to the nuclear suspensions (107 nuclei per
ml in DNase I digestion buffer) to a final concentration of 1
mM. Nuclei were then divided into portions of 1 to 2 ml and
incubated at 37°C for 5 min to ensure temperature equilibra-
tion. DNase I (Sigma Chemical Co.) was then added to a
final concentration of 0 to 0.6 jig/ml, and after 5 min at 37°C
the digestions were terminated by addition of EDTA (20
mM), sodium dodecyl sulfate (0.5%), and proteinase K (50
,ug/ml).
Preparation of DNA. DNA was purified from the DNase
I-digested nuclei after proteinase K treatment for 12 to 16 h
at 37°C. The solutions were extracted twice with phenol-
CHCl3 (2:1) and once with CHCl3, and the DNA was then
subjected to two successive ethanol precipitations, the sec-
ond from 2.5 M ammonium acetate. The DNA was sus-
pended in 10 mM Tris-hydrochloride (pH 7.6)-i mM EDTA
at a final concentration of 100 to 200 ,ug/ml. The concentra-
tion of each DNA sample was determined independently.
Plasmid DNA was purified from chloramphenicol-treated
Escherichia coli HB101 or TB1 by the alkaline extraction
method of Birnboim and Doly (1), followed by banding in a
cesium chloride-ethidium bromide density gradient.
Southern blot analysis. Restriction endonucleases (Be-
thesda Research Laboratories) were used according to the
recommendations of the supplier. Complete digestion of
DNA was monitored by an internal standard of DNA from
bacteriophage X.
For Southern blot analysis (33), 10 ,ug of restriction
endonuclease-digested DNA was fractionated by electropho-
resis through a 1% agarose gel. The gel was treated for 30
min with 0.5 M NaOH-1.5 M NaCl, followed by 60 min of
neutralization in 0.5 M Tris-hydrochloride (pH 7.6)-3 M
NaCl. The DNA was then blotted onto nitrocellulose (Mill-
ipore Corp.) in 6x SSC (1x SSC is 0.15 M NaCl plus 15 mM
sodium citrate) for 12 to 24 h. Filters were then air dried,
baked for 2 to 3 h at 80°C in a vacuum oven, and hybridized
as described below.
Molecular weight markers consisted of restriction frag-
ments of cloned MMTV DNA whose sizes had been deter-
mined by comparison with HindIII-digested X DNA or
restriction fragments of pBR322. The sizes of the markers
are 14.1, 12.4, 10.7, 9.8, 8.0, 6.5, 6.0, 4.7, 4.4, 2.0, and 1.3
kilobases (kb). All markers do not hybridize with all of the
probes used in the Southern blot experiments.
Blot analysis of RNA. Total cellular RNA was isolated by
dissolving washed cells in 6 M guanidinium thiocyanate-50
mM 2-mercaptoethanol-0.5% Sarkosyl-5 mM sodium citrate
(pH 7.0) (3) and then selectively pelleting the RNA by
centrifugation through 5.7 M CsCl-0.1 M EDTA (11). The
RNA pellets were dissolved in 10 mM Tris-hydrochloride
(pH 7.6)-i mM EDTA and precipitated with ethanol.
RNA (10 ,Lg) was fractionated on a 1% agarose gel
containing formaldehyde (17) and blotted to nitrocellulose
(Millipore) in 20x SSC (35). The filter was then air dried and
baked for 2 to 3 h at 80°C in a vacuum oven. Just before
hybridization as described below, the filter was washed
briefly in 3 x SSC to remove residual salt.
Filter hybridization. Blots were hybridized with 32P-la-
beled plasmid DNA nick translated as described by Feinst-
ein et al. (9) to a specific activity of 1 x 108 to 3 x 108
cpm/lpg. Specific hybridization conditions have been de-
scribed previously (27).
Three different hybridization probes were utilized. A
probe homologous to the entire MMTV genome consisted of
a mixture of plasmids pMTV1 (37) and a subclone of the 5'
portion of the proviral DNA located at Mtv-8 designated
pTC8 (27). The probe for indirect end labeling from the
internal EcoRI site toward the 5' LTR was plasmid pMTV3.3,
an EcoRI-BglII subclone of pMTV3 (18) inserted into the
EcoRI-BamHI sites of pUC8 (40). Indirect end labeling from
EcoRI toward the 3' LTR was accomplished with pMTV2.2,
an EcoRI-PstI subclone of pMTV2 (25).
RESULTS
Hormone-inducible changes in MMTV chromatin. The sen-
sitivity of proviral DNA to digestion by DNase I in isolated
nuclei was used as an assay to probe the chromatin structure













of MMTV genes in TlMl cells. Maps of DNA comprising
the genetic loci Mtv-8, Mtv-9, and Mtv-17 that are present in
TlMl cells with restriction sites relevant to the present
study are shown in Fig. 1. Nuclease sensitivity studies in
other gene systems have revealed two kinds of altered
chromatin structures associated with transcriptionally active
(or potentially active) genes: a moderate sensitivity to the
nuclease that usually extends throughout an entire active
transcription unit (41, 42) and sometimes well beyond (16),
and specific sites of nuclease hypersensitivity that are many
times located within and around active genes (7).
Nuclei were prepared from TlMl cells before and after a
9-h exposure to the synthetic glucocorticoid dexamethasone
(10-6 M) and were digested briefly with various amounts of
DNase I. DNA was then isolated, digested to completion
with EcoRI, and subjected to Southern blot analysis. The
extent of DNase I digestion was monitored by the size
distribution of DNA fragments on agarose gel electrophore-
sis before restriction endonuclease cleavage. In each prepa-
ration of nuclei, comparable levels of digestion were ob-
tained from a given concentration of DNase I. The Southern
blots were probed with nick-translated DNA specific for the
5' or 3' EcoRI fragments of the proviral units. These probes
could be used to compare the moderate DNase I sensitivity
of the six EcoRI fragments that contain proviral DNA
relative to each other and also to map potential sites of
DNase I hypersensitivity by indirect end labeling from the
EcoRI site internal to each proviral unit (see Fig. 1 and 4).
The results of such an experiment utilizing a 5'-specific
probe are shown in Fig. 2, in which the most prominent
bands are the expected 5' EcoRI fragments of 10.0 kb
(Mtv-17), 8.0 kb (Mtv-8), and 7.7 kb (Mtv-9). A site of
hypersensitivity that is defined by a DNase I-generated
subband of 4.8 kb was detectable in nuclei isolated from cells
that had been treated for 9 h with dexamethasone (lanes e
through h); this hypersensitivity was significantly less appar-
ent in nuclei from cells that had not been exposed to
hormone (lanes a through d), indicating that glucocorticoid
a b c d e t g h ij k I M









FIG. 3. DNase I sensitivity of the 3' portion of MMTV genes in
TlMl nuclei. The nitrocellulose filter from the Southern blot exper-
iment shown in Fig. 2 was probed with the 3' probe indicated in Fig.
4. Lanes are identical to those in the legend to Fig. 2.
induction of proviral gene transcription is indeed associated
with demonstrable changes in chromatin structure. In addi-
tion, two other sites of extremely weak hypersensitivity
were detectable and are defined by subbands of 5.8 and 5.3
kb. These sites did not appear to be markedly enhanced after
dexamethasone treatment, and although they were ex-
tremely weak, they were reproducibly seen in several prep-
arations of nuclei (e.g., see Fig. 6).
The analogous experiment utilizing a 3'-specific probe is
shown in Fig. 3, and the expected 3' EcoRI fragments of 9.7
kb (Mtv-9), 8.4 kb (Mtv-17), and 6.6 kb (Mtv-8) are apparent.
In addition, there are four rather diffuse DNase I-generated
subbands of 3.8, 3.3, 2.8, and 2.4 kb. Although all of the
subbands were detectable in nuclei from cells that had not
;been exposed to hormone (lanes a through d), the intensity
of the 3.8- and 2.4-kb bands markedly increased after
dexamethasone treatment (lanes e through h).
The positions of these DNase I-hypersensitive sites with
respect to MMTV sequences are shown in Fig. 4. The three
5' sites and three of the four 3' sites map to analogous
positions within the 5' and 3' LTRs of proviral DNA; two





FIG. 2. DNase I sensitivity of the 5' portion of MMTV genes in
TlMl nuclei. Purified DNA (10 p.g) from DNase I-treated nuclei was
digested to completion with EcoRI and subjected to Southern blot
analysis with the 5' probe indicated in Fig. 4. Lanes a through d,
Nuclei from cells not treated with dexamethasone; lanes e through
h, dexamethasone (10-6 M) was added 9 h before preparation of
nuclei; lanes i through 1, dexamethasone (10-6 M) was added
immediately before preparation of nuclei; lane M, size markers.
Nuclei (107/ml) were treated with DNase I for 5 min at 37°C at a
concentration of 0 jig/ml (lanes a, e, and i), 0.1 jig/ml (lanes b, f, andj), 0.3 ,ug/ml (lanes c, g, and k), or 0.6 jig/ml (lanes d, h, and l) .
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FIG. 4. DNase I-hypersensitive sites in MMTV genes. LTRs are
shown as hatched boxes. Areas of cross-hatching represent GREs.
The horizontal arrow defines the cap site and direction of viral RNA
transcription. Indirect-end-labeling probes are indicated. Type I
sites are shown as open vertical arrows; type II sites are shown as
















HORMONE-INDUCIBLE CHANGES IN MMTV CHROMATIN STRUCTURE




FIG. 5. Hormone-inducible synthesis of MMTV RNA in TlMl
cells. Total cellular RNA (10 ,ug in lanes a through d; 1 ,ug in lane e)
was fractionated by agarose gel electrophoresis in the presence of
formaldehyde, blotted to nitrocellulose, and probed with nick-trans-
lated DNA representing the entire MMTV genome. RNA was
prepared from TlMl cells treated with dexamethasone (106 M) as
follows: lane a, no dexamethasone; lane b, dexamethasone for 9 h;
lane c, dexamethasone for 9 h, and then cells were cultured without
dexamethasone for approximately six cell generations; lane d, same
as lane c with dexamethasone present during the last 9 h. Lane e
contains RNA from dexamethasone-treated M1.54, a clone of
MMTV-infected rat hepatoma cells (43).
in the 5' direction. The fourth 3' site maps to a position
within proviral DNA in, or very near, a glucocorticoid
receptor binding site that has been defined in vitro (25).
In addition to changes in hypersensitivity, another feature
of the DNase I digestion of nuclei from dexamethasone-
treated cells is the apparent differential nuclease sensitivity
of the six EcoRI restriction fragments. In particular, two
restriction fragments 8.0 kb (5'; Fig. 2) and 6.6 kb (3'; Fig. 3)
in size are comparatively resistant to DNase I; these frag-
ments correspond to the 5' and 3' portions of the proviral
unit (unit II) located at Mtv-8. This differential sensitivity
may be due to the lack of hypersensitive sites in this proviral
unit, or it may reflect differences between the three proviral
units in the kind of general, more moderate nuclease sensi-
tivity that extends throughout active transcription units.
Glucocorticoid-mediated activation of MMTV gene tran-
scription occurs very rapidly; the rate of MMTV RNA
synthesis is half-maximal after 8 to 9 min of hormone
treatment (38). If the hormone-mediated changes in chroma-
tin structure described above are a significant feature ofgene
activation, they would be expected to occur very rapidly. To
examine this point, a culture of TlMl cells was split, a
portion was used to prepare the nuclei analyzed in Fig. 2 and
3, lanes a through d (no dexamethasone treatment), and
dexamethasone (10-6 M) was added to the remainder. The
hormone-treated cells were then immediately placed on ice,
and nuclei were prepared for DNase I digestion, a process
taking ca. 1 h (at 0 to 4°C). As shown in Fig. 2 and 3, lanes
i through 1, there was essentially no difference in the pattern
or intensity of the hypersensitive sites between this very
brief hormone treatment and one that extended for 9 h (lanes
e through h). Thus, the hormone-mediated alterations in
DNase I hypersensitivity occur very rapidly. In contrast, the
differences in the general nuclease sensitivity of the proviral
units that were apparent after longer dexamethasone treat-
ment were not seen with the short exposure to hormone,
suggesting that these changes may require relatively long,
continuous exposure to glucocorticoids before they occur.
Stability of hormone-induced chromatin alterations. To
assess the stability of the hormone-induced changes in
chromatin structure, TlMl cells were treated for 9 h with
10-6 M dexamethasone (the same culture analyzed in Fig. 2
and 3, lanes e through h), and the cells were then washed
until the dexamethasone concentration was less than 10-14
M. The washed cells were propagated for approximately six
cell generations, at which time dexamethasone (10-6 M) was
again added to a portion of the culture.
These conditions led to an induction of MMTV RNA
during the first hormone treatment (Fig. 5, lanes a and b), a
loss of detectable viral RNA synthesis during hormone
withdrawal (lane c), and reinduction when hormone was
added a second time (lane d). The results in Fig. 5 also serve
to demonstrate that there is nothing grossly aberrant in the
expression of endogenous MMTV genes in TlMl cells. The
two MMTV RNAs that can be detected are identical in size
to RNAs synthesized in MMTV-infected rat hepatoma cells
(Fig. 5, lane e). With the 28S and 18S rRNAs as markers, the
two MMTV RNA molecules are ca. 8.8 and 3.6 kb in size,
corresponding to MMTV genomic RNA that is the primary
transcript of proviral DNA and a spliced product, respec-
tively.
Nuclease sensitivity of MMTV chromatin after hormone
withdrawal and secondary stimulation is shown in Fig. 6 and
7. Hypersensitivity at the 5' site defined by the 4.8-kb
subband was diminished after hormone withdrawal (Fig. 6,
lanes a through c), becoming comparable to that seen in
nuclei prepared from cells that had not been exposed to
dexamethasone (Fig. 2, lanes a through d). In like fashion
the hypersensitive site at the analogous position in the 3'
LTR (defined by the 3.8-kb subband) was less apparent after
hormone withdrawal, as was the site defined by the 2.4-kb
subband (Fig. 7, lanes a through c). These sites reappeared
when dexamethasone was added to withdrawn cells, and
MMTV RNA synthesis was again induced (Fig. 6 and 7,
lanes d through f). These hypersensitive sites whose pres-
ence correlates with the presence of glucocorticoids have







FIG. 6. Stability of hormone-induced changes in MMTV chro-
matin in the 5' LTR. Purified DNA (10 jig) from DNase I-treated
TlMl nuclei was digested to completion with EcoRI and subjected
to Southern blot analysis with the 5' probe indicated in Fig. 4. Cells
were treated with dexamethasone (10-6 M) for 9 h (the same culture
analyzed in Fig. 2 and 3, lanes e through h), washed, and then
propagated in the absence of hormone for approximately six cell
generations. Lane M, Size markers; lanes a through c, no further
dexamethasone treatment; lanes d through f, dexamethasone (10-6
M) was added 9 h before preparation of the nuclei. Nuclei (107/ml)
were treated with DNase I for 5 min at 37°C at a concentration of 0
,ug/ml (lanes a and d), 0.1 ,ug/ml (lanes b and e), or 0.3 jig/ml (lanes
c and f).













been termed type I hypersensitive sites, and they are indi-
cated by open arrows in Fig. 4. In contrast to type I sites, the
nuclease hypersensitivity that is defined by subbands of 5.8
and 5.3 kb (5') and 3.3 and 2.8 kb (3') appears not to be
markedly hormone dependent. These sites have been desig-
nated type II hypersensitive sites and are shown by solid
arrows in Fig. 4.
DISCUSSION
The results presented here demonstrate that altered chro-
matin conformations of endogenous MMTV proviral DNA
can be defined by their sensitivity to DNase I in isolated
nuclei. The altered conformations are reflected in specific
sites of DNase I hypersensitivity, as well as in differential
moderate nuclease sensitivity of entire proviral transcription
units.
The observed hypersensitive sites are of two types. Type
I hypersensitive sites are those that are induced in the
presence of glucocorticoid hormones, and they regress and
reappear coinciding with periods of hormone withdrawal and
readdition. The type I sites map within, or very near, DNA
sequences that comprise specific in vitro binding sites for the
glucocorticoid receptor, and it is tempting to speculate that
these sites are a direct result of receptor binding. Interest-
ingly, even in the absence of glucocorticoids, weak DNase I
hypersensitivity is associated with type I sites. It is conceiv-
able that this weak hypersensitivity is indicative of receptor
that is bound at these sites in the absence of hormone;
specific in vitro binding of receptor to GRE sequences in the
absence of hormone has not been examined. Type II sites
are not markedly hormone dependent. They map to corre-
sponding positions within the 5' and 3' LTR sequences, ca.
500 and 1,000 bp to the 5' side of the type I site that is in or
near the GRE. These type II sites may serve to mark one or
more of the proviral units for hormone activation. By this
view the type II hypersensitive sites may be indicative of
molecular signals that program TlMl cells to allow a pro-
ductive interaction between the receptor-hormone complex
and GRE sequences that are normally not recognized in
C57BL/6 cells, resulting in the unusual phenotype of endo-
genous MMTV gene expression in TlMl. Type II sites in the
5' LTR are particularly weak, although they are reproduc-
ibly seen in different preparations of nuclei. To some extent
this may be a reflection of the fact that these sites are distal
to the indirect-end-labeling probe (Fig. 4). If multiple DNase
I cleavage events occur in a single LTR, the intensity of
subbands generated by sites most distal to the probe will be
decreased.
All of the DNase I-generated subbands are relatively
diffuse; the band width increases with decreasing size of
subband, and in all cases it corresponds to ca. 100 to 200 bp
of DNA. This may indicate that the nuclease recognizes a
chromatin domain that extends over a DNA region of this
size and cleaves relatively nonspecifically within this do-
main. Evidence suggests that this is the case for the nucle-
ase-hypersensitive region near the 5' end of the chicken
,B-globin gene (20), where nuclease hypersensitivity appears
to result from a DNA sequence that is free of nucleosomes
and that instead may be associated with a specific protein
that is required for the in vitro assembly of chromatin that
contains the hypersensitive domain (8).
The presence of the three endogenous proviral units in
TlMl (see Fig. 1) potentially allows examination of the
extent to which the site of provirus insertion plays a role in
the observed chromatin conformations. Perhaps the clearest
statement that can be made in this regard is based on the








FIG. 7. Stabilitv of hormone-induced changes in MMTV chro-
matin in and near the 3' LTR. The nitrocellulose filter from the
Southern blot experiment shown in Fig. 6 was probed with the 3'
probe indicated in Fig. 4. Lanes are identical to those in the legend
to Fig. 6.
relative DNase I resistance of proviral DNA located at
Mtv-8 (unit II; Fig. 2 and 3). Cloned Mtv-8 DNA from TlMl
that has been transfected into mouse or rat cells is able to
specify glucocorticoid-regulated transcription, indicating that
this endogenous provirus contains a functional hormone-re-
sponsive promoter (P. Burdick and D. Peterson, unpub-
lished data). Thus, the relative DNase I resistance of this
endogenous unit apparently does not result from an inherent
inability to be recognized as a hormone-responsive gene and
suggests that the cells are able to maintain distinct chromatin
structures that are determined by factors related to the site
of provirus insertion and not by the nature of the transcrip-
tion unit itself. With regard to the presence of DNase I
hypersensitive sites in the individual proviral units, the
experiments presented here have not specifically addressed
the question of which of these units actually contains type I
or type II sites or whether these sites are present simultane-
ously in the 5' and 3' LTRs of a single proviral unit; the
indirect-end-labeling experiments were performed with
probes internal to the MMTV genome. However, the subband
of 4.8 kb that defines the type I site in the 5' LTR does not
contain the HindIll site that is present only in the 5' EcoRI
fragment of Mtv-9 (unpublished data), and the relative
DNase I resistance of the EcoRl restriction fragments con-
taining the proviral unit at Mtv-8 suggests that this provirus
does not contain hypersensitive sites. Thus, it seems most
likely that the observed sites of DNase I hypersensitivity are
primarily located within proviral DNA at Mtv-17. It has not
been determined which proviral unit(s) is transcriptionally
active in TlMl cells.
Hormone-induced changes in MMTV chromatin are not
unique to TlMl cells. Preliminary observations indicate that
sites of DNase I hypersensitivity similar to those described
here for TlMl are present in cells exogenously infected with
MMTV (unpublished data). In addition, Zaret and Yamamoto
(44), utilizing transfected mouse L cells, reported the pres-
ence of sites of DNase I hypersensitivity within 5' and 3'
MMTV LTR sequences present in a MMTV-herpes simplex
virus tk gene construct. These sites are very similar to the
type I and type II sites seen in TlMl cells; however, their
work revealed only one type I site (within the GRE) and one
type II site in each LTR, and their construction did not
contain DNA sequences that comprise the receptor-binding
site that is not in the LTR and where a type I site has been
mapped in TlMl (see Fig. 4).














HORMONE-INDUCIBLE CHANGES IN MMTV CHROMATIN STRUCTURE
structure are associated with estrogen activation of the
chicken vitellogenin II gene (2). In liver cells this gene is
marked internally and in 3' flanking sequences with sites of
nuclease hypersensitivity before hormone treatment; these
are analogous to the type II sites described here. When 17
,B-estradiol is administered, three new hypersensitive sites
are induced on the 5' side of the gene. Two of these sites are
apparently stably maintained through cell division in the
absence of the continuous presence of the hormone, and the
third site is present only during periods of hormone treat-
ment and, analogous to type I sites in MMTV DNA, it maps
to a DNA sequence that contains a specific in vitro binding
site for the estrogen receptor (15).
One attractive view is that gene activation by steroid
hormones occurs by a mechanism similar to that of transcrip-
tional enhancer elements (4). Indeed, indirect experiments
have shown that activity of the simian virus 40 enhancer
element depends on its interaction with a trans-acting cellu-
lar factor, presumably a protein (32). Such factors could be
the functional analogs of hormone-activated steroid recep-
tors. Furthermore, like the nuclease hypersensitivity asso-
ciated with specific steroid receptor binding sites, hypersen-
sitivity has been shown to be associated with enhancer
elements in simian virus 40 (6, 30), polyoma (14), and
immunoglobulin genes (5, 23, 24). It seems likely that these
altered chromatin structures may reflect, or actually encode,
important mechanistic features of these regulatory DNA
sequences.
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